ACRS= great buying opp again
ACRS ..MC $57 M / Cash $115 M / 2 APPROVED Drugs/ Third Drug with POSITIVE P3 DATA = 10+BAGGER GEM
(ACRS)--Market-Cap $43 M --Cash $115 M till Q3 2021---2 approved Drugs / Another Drug successful in Phase 3 trial for which there are NO FDA approved treatment ---/New Partner Deal(s) also expected during Q4 = MEGA Rebound Gem with 1000% Upside potential
Actively Seeking a Commercialization Partner for RHOFADE® (oxymetazoline hydrochloride) cream, 1%
Aclaris will also seek strategic partners for ESKATA® (hydrogen peroxide) topical solution, 40% (w/w).
Aclaris is actively seeking a strategic partner to commercialize its drug candidate A-101 45% Topical Solution, an investigational compound being developed as a potential treatment for verruca vulgaris (common warts). The Company’s two ongoing Phase 3 pivotal clinical trials, THWART-1 and THWART-2, in which A-101 45% Topical Solution is being evaluated as a potential treatment for common warts, are progressing as planned. Aclaris has completed enrollment of more than 1,000 patients across these two trials, and data from both trials are expected in the second half of 2019.
Aclaris is actively seeking a development and commercialization partner for its drug candidates, ATI-501 (oral) and ATI-502 (topical), which are investigational Janus Kinase (JAK) 1/3 inhibitor compounds for the potential treatment of alopecia.
AI
